Market Overview

The Global Biodefense Market was valued at USD 16,061.1 million in 2023 and is expected to reach USD 23,910.9 million by 2031 while growing at a CAGR of 5.1% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global biodefense market growth. Biological defense involves employing measures and strategies to protect against and respond to biological threats like infectious diseases, bioterrorism, and pandemics. The primary objective is to enhance the resilience of communities, nations, and the global population, mitigating the impact of biological events.

The biodefense market is poised for substantial growth due to the increasing threat of bioterrorism and advancements in biotechnology, genomics, and diagnostics. However, challenges like economic instability, global financial crises, and stringent regulatory processes with lengthy approval timelines may impede market expansion.

Furthermore, the global biodefense industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Analysis

The Global Biodefense Market is segmented among Anthrax, Botulism, Smallpox, Nuclear, and Other Products, based on product. In 2023, Anthrax accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Biodefense Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Emergent BioSolutions Inc., Siga Technologies Inc., Bavarian Nordic, National Resilience, Inc., Ichor Medical Systems, Nighthawk Biosciences, Inc. (Elusys Therapeutics Inc.), Dynavax Technologies, and XOMA Corporation.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Biodefense Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Biodefense Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Biodefense Market Segmentation, By Product

• Global Biodefense Market Share Analysis, By Product

• Global Biodefense Market Growth Analysis, By Product

• Global Biodefense Market Trends, By Product

o Anthrax

o Botulism

o Smallpox

o Nuclear

o Other Products

6. Global Biodefense Market Segmentation, By Region

• Global Biodefense Market Share Analysis, By Region

• Global Biodefense Market Growth Analysis, By Region

• Global Biodefense Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

7. Competitive Landscape

• Emergent BioSolutions Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Siga Technologies Inc.

• Bavarian Nordic

• National Resilience, Inc.

• Ichor Medical Systems

• Nighthawk Biosciences, Inc. (Elusys Therapeutics Inc.)

• Dynavax Technologies

• XOMA Corporation

 *Similar analysis will be provided for each company listed above.